FDA Risk Committee To Consider Whether Earlier Information Is Really Better
This article was originally published in The Tan Sheet
Executive Summary
FDA is scrutinizing how it can make timely releases of safety information without sacrificing completeness and accuracy
You may also be interested in...
FDA Risk Communication Panel’s Charter Is Tweaked As Members Are Named
FDA is modifying the charter for its Risk Communication Advisory Committee to reflect new powers the agency gained as part of the passed FDA reauthorization bill
Industry Involvement In Guidance Development Encouraged By FDA Working Group
In a report on best practices for guidance development, FDA encourages outside groups to submit their own draft guidance proposals to help make the overall process more efficient.
Industry Involvement In Guidance Development Encouraged By FDA Working Group
In a report on best practices for guidance development, FDA encourages outside groups to submit their own draft guidance proposals to help make the overall process more efficient.